skip to Main Content

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
Among patients with metastatic pancreatic cancer, combination chemotherapy with fluorouracil, leucovorin, irinotecan, and oxaliplatin (FOLFIRINOX) leads to longer overall survival than gemcitabine therapy.

We compared the efficacy and safety of a modified FOLFIRINOX regimen with gemcitabine as adjuvant therapy in patients with resected pancreatic cancer. Read more . . . 


Back To Top